Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1F | P30939 | 8/20 | 0.49 |
| ▸ | WDR5 | P61964 | 1/20 | 0.48 |
| ▸ | GPR6 | P46095 | 7/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4493318 | 0.93 | ALDH1A1 (0.47) | HTR1FGPR6KMT2A | |
| SCHEMBL4504844 | 0.90 | HTR1F (0.53) | HTR1FWDR5GPR6KMT2AHPGD | |
| SCHEMBL10259172 | 0.90 | GPR6 (0.54) | HTR1FGPR6KMT2A | |
| Hydrochloric Acid SCHEMBL4506328 | 0.89 | GPR6 (0.53) | HTR1FGPR6KMT2A | |
| SCHEMBL4505771 | 0.89 | HTR1F (0.47) | HTR1FWDR5GPR6KMT2AHPGD | |
| SCHEMBL12020872 | 0.86 | HTR1F (0.51) | HTR1FWDR5KMT2AHPGD | |
| SCHEMBL10261500 | 0.83 | HTR1F (0.59) | HTR1FWDR5HPGD | |
| SCHEMBL10267789 | 0.83 | HTR1F (0.57) | HTR1FWDR5KMT2AHPGD | |
| SCHEMBL4492168 | 0.83 | HTR1F (0.48) | HTR1FGPR6 | |
| SCHEMBL4506654 | 0.82 | HTR1F (0.53) | HTR1FGPR6KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7608629-B2 | (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 2009-10-27 | — | — | US | disclosed |
| US-20060211734-A1 | (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists | ELILILLY AND COMPANY (US) | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211734-A1 | (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists | HTR1A, HTR1F, HTR5A | HTR1F 2/4885WDR5 4022/4885GPR6 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.